Английская Википедия:IONIS-GCCRRx

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description

Шаблон:Drugbox

IONIS-GCCRRx, also known as ISIS-426115, is an antiglucocorticoid which is under development by Ionis Pharmaceuticals (formerly Isis Pharmaceuticals) for the treatment of diabetes mellitus type 2.[1][2] It has also been under investigation for the treatment of Cushing's syndrome, but no development has been reported.[1] The drug is an antisense oligonucleotide against the glucocorticoid receptor.[1] As of December 2017, it is in phase II clinical trials for diabetes mellitus type 2.[1]

References

Шаблон:Reflist

Шаблон:Glucocorticoid receptor modulators Шаблон:Systemic-hormonal-drug-stub